Rosemont Pharmaceuticals is a renowned brand with a mission to develop, manufacture, and supply innovative medicines that prioritize patient needs worldwide. With over 50 years of experience, our focus has been on supporting patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have played a key role in establishing best practices for patients with swallowing difficulties.

Our portfolio includes more than 130 oral liquid medicines across various therapeutic areas, including 70 licensed products. We also offer 9 products licensed for use with PEG/NG tubes. Our commitment to quality is evident, as all our products, both licensed and 'specials,' are made to the highest standards under GMP.

We prioritize education and supporting healthcare professionals, offering a range of educational materials to address medication management challenges. We advocate for the use of liquid medications, providing resources for key patient groups. Rosemont Pharmaceuticals remains dedicated to expanding our range of medicines and obtaining licenses for our 'specials' wherever feasible.

With our cutting-edge manufacturing site in Leeds, UK, we produce over 4 million bottles of liquid medicine annually. We are continuously investing in technologies to enhance our capabilities and satisfy the needs of the NHS, healthcare professionals, and the patients they serve. For more information about Rosemont Pharmaceuticals and our commitment to patient-focused care, please refer to our corporate brochure